PI Industries
Growth unavailable
Q2 FY2027 · Period ended 30 Sep 2026
Basis: Consolidated unaudited results approved 4 Nov 2026; limited review
Reported revenue (₹ million, except EPS in ₹): 17,018
Read summary and comparison caveats
PI Industries reported consolidated September-quarter revenue from operations of ₹17,018 million versus ₹18,723 million a year earlier. Profit before tax was ₹1,840 million versus ₹5,253 million, and profit for the period was ₹1,222 million versus ₹4,093 million. No exceptional item is printed for either quarter.
- The full 15-page own-site-linked document was read, including separate standalone and consolidated statements, notes, cash flows, segment information and review reports. Consolidated figures on PDF page 7 are used here; amounts remain in rupees million without conversion. Comparisons are with the quarter ended 30 Sep 2025, not the half year. Key statement, notes, cash-flow and segment pages were also inspected visually because the text layer misreads some digits.
- Standalone revenue of ₹15,335 million and profit of ₹2,071 million are not substituted for consolidated revenue or profit. The consolidated statement includes the ₹35 million share of profit of the associate and joint venture before tax. Total comprehensive income is separate from profit for the period, and EPS is not annualised.
- Annexure I reports agro-chemicals segment revenue of ₹16,280 million and pharma revenue of ₹759 million before ₹21 million intersegment elimination. Segment pre-tax results are ₹2,473 million for agro chemicals and a ₹601 million loss for pharma, with a negative ₹32 million intersegment adjustment. These are segment results, not separate group-profit figures.
- The ₹1,260 million contingent-consideration write-back and ₹229 million labour-code expense in the consolidated notes relate to the year ended 31 Mar 2026. They are not current-quarter exceptional items. The separate standalone investment provision is not a consolidated-quarter charge.
- Consolidated operating cash inflow of ₹8,899 million versus ₹2,476 million covers six months. It is not quarterly profit or quarterly cash flow. The consolidated group includes subsidiaries, a controlled trust, associate and joint venture, including the joint venture subsidiary from 3 Jul 2026.
- Price Waterhouse gives an unmodified limited-review conclusion, not an audit opinion. It relies on other auditors for certain entities and on management-provided unreviewed results for four subsidiaries judged immaterial to the group; the conclusion is not modified for those matters.
- Original source-attributed factual summary, not a forecast, recommendation or completeness claim. Current exposed disclaimer, privacy and security policies were checked; trademark restrictions and the separate QIP-document restrictions are not treated as a general financial-results reuse licence or a general prohibition. No explicit restriction on a short factual financial summary was found in the checked corporate pages. No calculated growth or unprinted QoQ is added.
Checked 19 Nov 2026
Open original filing